Keyword: Lonza

Markets & Companies

Expert Interview: Matthew Moorcroft, Lonza

17.10.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...

Chemistry & Life Sciences

The Rise of HPAPI Molecules

10.09.2020 -

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

News

Lonza Expanding Microbial Facility at Visp

05.08.2020 -

Swiss CDMO Lonza is expanding its microbial manufacturing facility in Visp, Switzerland, to add mid-scale (3,000 l) commercial manufacturing for multiple customers and in...

News

Pierre-Alain Ruffieux new CEO of Lonza

09.06.2020 - Pierre-Alain Ruffieux has been appointed CEO of Swiss CDMO Lonza, with effect from 1 November 2020. The new chief executive will succeed Marc Funk, who led the company from March...

News

Pfizer to Make Space for Vaccine Production

13.05.2020 -

To save manufacturing space for its growing vaccines plans, Pfizer has said it will outsource production of some of its pharmaceutical portfolio. The work is planned to...

News

Pfizer to Make Space for Vaccine Production

12.05.2020 - To save manufacturing space for its growing vaccines plans, Pfizer has said it will outsource production of some of its pharmaceutical portfolio. The work is planned to be shared...

News

Lonza Teams up with Moderna on Covid-19 Vaccine

04.05.2020 -

Swiss fine chemicals producer and CDMO Lonza has signed a 10-year worldwide strategic collaboration agreement with Cambridge, Massachusetts-based US biotech Moderna to...

Markets & Companies

Agrochemical and Custom Manufacturing Industry: Connected Fates

20.04.2020 -

The fate of the agrochemical innovation, development, product launch and production are strongly linked to the parallel development of the fine chemicals and custom...